QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Rogers, L. R. Articles by Tejwani, S. Search for Related Content PubMed PubMed Citation

Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy

Hermelin Brain Tumor Center, Departments of Neurosurgery (L.R.R., S.E.R.) and Neurology (L.R.R.), Henry Ford Hospital, Detroit, MI 48202, and Josephine Ford Cancer Center (S.T.), Detroit, MI 48202; USA

¹ Address correspondence to Lisa R. Rogers, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202 (lrogers{at}neuro.hfh.edu).

Abstract

We report a durable (12-month) response to capecitabine monotherapy, shown clinically, by MRI, and by cerebrospinal fluid analysis, in a patient with leptomeningeal metastasis from breast cancer.

This article has been cited by other articles:

				M. C. Chamberlain Neoplastic Meningitis Oncologist, September 1, 2008; 13(9): 967 - 977. [Abstract] [Full Text] [PDF]

				December 13 Highlight and Commentary: Capecitabine-induced multifocal leukoencephalopathy Neurology, December 13, 2005; 65(11): 1685 - 1685. [Full Text] [PDF]